News Column

DGAP-News: Proteros biostructures GmbH Announces Election of Prof. Eric-Paul PÂques, CEO of GrÜnenthal, as New Supervisory Board Member

February 19, 2014

DGAP-News: Proteros biostructures GmbH / Key word(s): Change of Personnel Proteros biostructures GmbH Announces Election of Prof. Eric-Paul PÂques, CEO of GrÜnenthal, as New Supervisory Board Member 20.02.2014 / 08:00 --------------------------------------------------------------------- PRESS RELEASE Proteros Announces Election of Prof. Eric-Paul PÂques, CEO of GrÜnenthal, as New Supervisory Board Member Munich, Germany - 20 February 2014 - Proteros biostructures announced today that its shareholders confirmed the appointment of Prof. Eric-Paul PÂques as a new member of the Supervisory Board. Prof. PÂques is presently CEO and Chairman of the Corporate Executive Board of GrÜnenthal, an international research-based pharmaceutical company headquartered in Aachen, Germany. Prior to his more than 20 years at GrÜnenthal, he worked as the Head of Research at Behringwerke AG, in Germany. Prof. PÂques received a doctorate in Chemistry from the UniversitÉ Catholique de Louvain. 'We are delighted to have Eric-Paul joining our board' commented Dave Lemus, Chairman of the Supervisory Board of Proteros. 'His extensive experience in the pharmaceutical industry will prove invaluable to Proteros as the company accelerates its transition to the next phase of its development.' About Proteros biostructures GmbH Proteros biostructures, located in Martinsried/Munich, is a privately-held company, focussing on protein-structure accelerated lead discovery. Proteros has established a unique and powerful platform for the integration of protein crystallography, biophysics - particularly kinetic and thermodynamic profiling-, tailor-made protein production for biophysical applications and Medicinal Chemistry. Proteros collaborates with more than 80 pharmaceutical and biotechnology clients in North America, Europe and Asia. For more information, visit: www.proteros.com Contacts: Dr. Torsten Neuefeind, CEO Proteros biostructures GmbH Email: neuefeind@proteros.deFor Press enquiries: MC Services AG, Katja Arnold Email: katja.arnold@mc-services.eu Phone: +49 89 210 228-0 End of Corporate News --------------------------------------------------------------------- 20.02.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- 253362 20.02.2014


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: DGAP Corporate News


Story Tools